Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.

Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.

Item

http://www.wikidata.org/entity/Q38851239

Q38851239

about

Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.

Item

http://www.wikidata.org/entity/Q38851239

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Retrospective evaluation of co ...... r platinum-based chemotherapy.

@en

type

Item

label

Retrospective evaluation of co ...... r platinum-based chemotherapy.

@en

prefLabel

Retrospective evaluation of co ...... r platinum-based chemotherapy.

@en

P1476

Retrospective evaluation of co ...... or platinum-based chemotherapy

@en

P2093

Audrey Emmanuelle Dugué

http://www.w3.org/2001/XMLSchema#string

Bernard Gery

http://www.w3.org/2001/XMLSchema#string

Carmen Florescu

http://www.w3.org/2001/XMLSchema#string

David Blanchard

http://www.w3.org/2001/XMLSchema#string

Dominique De Raucourt

http://www.w3.org/2001/XMLSchema#string

Radj Gervais

http://www.w3.org/2001/XMLSchema#string

P2860

Human papillomavirus and survival of patients with oropharyngeal cancer.

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis.

Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients.

Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck

Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck

Severe radiation dermatitis in patients with locally advanced head and neck cancer treated with concurrent radiation and cetuximab.

Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: a systematic review and meta-analysis of published studies.

Cisplatin, cetuximab, and radiation in locally advanced head and neck squamous cell cancer: a retrospective review.

P2888

s00405-017-4550-7

P304

2883-2889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00405-017-4550-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

274

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuel Babin

Audrey Rambeau

P577

2017-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084517755

http://www.w3.org/2001/XMLSchema#string

P698

28382396

http://www.w3.org/2001/XMLSchema#string

P921

cetuximab

Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.

about

Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921